1-5 of 5
Stephen B. Baylin
Close
Sort by
Journal Articles

Demethylating Agents Reprogram Myelodysplastic Syndrome and Leukemia Cells, Sensitizing Them To Poly-(ADP)-Ribose Polymerase Inhibitors

Carine Robert, PhD, Nidal E Muvarak, MS, Vu H. Duong, MD, Maria R. Baer, MD, Stephen B. Baylin, MD, Feyruz Rassool, PhD
Journal: Blood
Blood (2013) 122 (21): 3778.
https://doi.org/10.1182/blood.V122.21.3778.3778
Published: 2013
Journal Articles

Epigenetic Regulation In Lymphoid Malignancies

Stephen B. Baylin, MD
Journal: Blood
Blood (2010) 116 (21): SCI-28.
https://doi.org/10.1182/blood.V116.21.SCI-28.SCI-28
Published: 2010
Journal Articles

Changes in Promoter Methylation and Gene Expression in Patients with MDS and MDS-AML Treated with 5-Azacitidine and Sodium Phenylbutyrate.

Steven D. Gore, MD, Stephen B. Baylin, MD, Tianna Dauses, RN, Michael R. Grever, MD, Anchalee Jiemjit, MS, Jasper Manning, MS, Carole B. Miller, MD, Anthony J. Murgo, MD, James A. Zwiebel, MD, James G. Herman, MD
Journal: Blood
Blood (2004) 104 (11): 469.
https://doi.org/10.1182/blood.V104.11.469.469
Published: 2004
Journal Articles

p15 INK4B CpG Island Methylation in Primary Acute Leukemia Is Heterogeneous and Suggests Density as a Critical Factor for Transcriptional Silencing

Elizabeth E. Cameron, Stephen B. Baylin, James G. Herman
Journal: Blood
Blood (1999) 94 (7): 2445–2451.
https://doi.org/10.1182/blood.V94.7.2445.419k19_2445_2451
Published: 1999
Journal Articles

Hypermethylation of the DAP-Kinase CpG Island Is a Common Alteration in B-Cell Malignancies

Rachel A. Katzenellenbogen, Stephen B. Baylin, James G. Herman
Journal: Blood
Blood (1999) 93 (12): 4347–4353.
https://doi.org/10.1182/blood.V93.12.4347
Published: 1999